サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1691777

同種骨移植市場- 世界の産業規模、シェア、動向、機会、予測、用途別、タイプ別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

Bone Allografts Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Type, By End-user, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 182 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.32円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

同種骨移植市場- 世界の産業規模、シェア、動向、機会、予測、用途別、タイプ別、エンドユーザー別、地域別セグメント、競合、2020年～2030年
出版日: 2025年03月24日
発行: TechSci Research
ページ情報: 英文 182 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

同種骨移植の世界市場規模は2024年に14億5,000万米ドルとなり、予測期間では2030年までCAGR 7.25%で目覚ましい成長が予測されています。

同種骨移植の世界市場は、高齢化人口の増加、整形外科疾患の増加、医療技術の進歩などを背景に、近年大きな成長を遂げています。同種骨移植は、ドナーからレシピエントへの骨組織の移植を伴うもので、整形外科手術や歯科手術の重要な一部となっています。同種骨移植は、ヒトドナーからの組織移植片であり、様々な整形外科的および歯科的用途に使用されます。主に、骨欠損、骨折、脊椎固定、関節再建、歯科治療などの手術に使用されます。同種骨移植は、自家骨移植（患者自身の体から採取した骨組織）に代わる実行可能な選択肢として機能し、骨の治癒を促進し、痛みや回復時間を短縮する能力により人気を博しています。2024年の記事によると、英国では75歳から84歳の推定63％が筋骨格系の疾患と共存しており、これは全年齢層の中で最も高い有病率です。全体として、筋骨格系疾患の有病率は年齢とともに上昇する傾向にあり、高齢者人口に大きな影響を与えることが強調されています。

市場概要
予測期間 2026-2030
市場規模：2024年 14億5,000万米ドル
市場規模：2030年 21億9,000万米ドル
CAGR：2025年～2030年 7.25%
急成長セグメント 脱灰骨基質
最大市場 北米

変形性関節症、骨折、脊椎変形などの整形外科疾患の世界の有病率は増加傾向にあります。この動向は同種骨移植の需要に拍車をかけています。同種骨移植は、これらの疾患に対処するための外科的介入において極めて重要だからです。低侵襲手術やロボット支援手術など、手術手技の技術的進歩が同種骨移植の採用を増加させています。これらの技術は、骨移植術の精度と有効性を高めています。高齢化社会は、骨粗鬆症や退行性関節疾患など、加齢に伴う骨の問題を抱えやすいです。高齢者人口は増加の一途をたどっており、同種骨移植の需要は大幅に増加すると予想されます。組織移植を規制する厳格な枠組みにより、同種骨移植の安全性と品質が向上しています。これが消費者の信頼と市場の成長を後押ししています。同種骨移植の利点に関する患者および医療専門家の意識の高まりが、外科手術における同種骨移植移植片の受け入れと利用を高めています。

主な市場促進要因

筋骨格系障害の発生率の増加が同種骨移植の世界市場を牽引

主な市場課題

サプライチェーンの制約

主要市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の同種骨移植市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 用途別（歯科、脊椎、再建および外傷学、その他）
    • タイプ別（同種皮質骨移植、同種海綿骨移植、同種皮質海綿骨移植、脱灰骨基質）
    • エンドユーザー別（病院・歯科医院、整形外科・外傷センター、その他）
    • 地域別
    • 企業別（2024年市場上位5社のシェア）
  • 市場マップ
    • 用途別
    • タイプ別
    • エンドユーザー別
    • 地域別

第6章 北米の同種骨移植市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の同種骨移植市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • フランス
  • 英国
  • イタリア
  • ドイツ
  • スペイン

第8章 アジア太平洋地域の同種骨移植市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国

第9章 南米の同種骨移植市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの同種骨移植市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • アプリケーションの起動

第13章 競合情勢

  • Zimmer Biomet inc.
  • Medtronic inc.
  • Lynch Biologics, LLC
  • Biomatlante S.A
  • Stryker Corporation
  • Royal Biologics, Inc.
  • Johnsons & Johnsons
  • Smith & Nephew plc
  • Baxter International Inc
  • Xtant Medical Hldgs.

第14章 戦略的提言

第15章 調査会社について・免責事項

目次
Product Code: 17399

The Global Bone Allografts Market was valued at USD 1.45 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.25% through 2030. The global bone allografts market has witnessed substantial growth in recent years, driven by an increasing aging population, rising cases of orthopedic disorders, and advancements in medical technology. Bone allografts, which involve the transplantation of bone tissue from a donor to a recipient, have become a crucial part of orthopedic and dental procedures. Bone allografts are tissue grafts sourced from a human donor and are used for various orthopedic and dental applications. They are primarily employed in surgeries to treat bone defects, fractures, spinal fusion, joint reconstruction, and dental procedures. Bone allografts serve as a viable alternative to autografts (bone tissue from the patient's own body) and have gained popularity due to their ability to promote bone healing and reduce pain and recovery time. According to a 2024 article, an estimated 63% of individuals aged 75 to 84 in the United Kingdom were living with a musculoskeletal condition, the highest prevalence among all age groups. Overall, the prevalence of musculoskeletal conditions tends to rise with age, highlighting the significant impact on the elderly population.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.45 Billion
Market Size 2030USD 2.19 Billion
CAGR 2025-20307.25%
Fastest Growing SegmentDemineralized Bone Matrices
Largest MarketNorth America

The global prevalence of orthopedic disorders, including osteoarthritis, fractures, and spinal deformities, is on the rise. This trend has fueled the demand for bone allografts, as they are crucial in surgical interventions to address these conditions. Technological advancements in surgical techniques, such as minimally invasive surgeries and robotic-assisted procedures, have increased the adoption of bone allografts. These techniques enhance the precision and efficacy of bone grafting procedures. The aging population is prone to age-related bone issues, such as osteoporosis and degenerative joint diseases. As the elderly population continues to grow, the demand for bone allografts is expected to rise significantly. Stringent regulatory frameworks governing tissue transplantation have improved the safety and quality of bone allografts. This has bolstered consumer confidence and market growth. Increased awareness among both patients and healthcare professionals about the benefits of bone allografts has led to higher acceptance and utilization of these grafts in surgical procedures.

Key Market Drivers

Rising Incidence of Musculoskeletal Disorders is Driving the Global Bone Allografts Market

Musculoskeletal disorders have become a significant global health concern, affecting millions of people across the world. These disorders encompass a wide range of conditions that impact the muscles, bones, tendons, ligaments, and other parts of the musculoskeletal system. Conditions like osteoarthritis, osteoporosis, fractures, and spinal disorders have been on the rise due to various factors such as aging populations and sedentary lifestyles. To address the growing demand for musculoskeletal treatments, the global bone allografts market is experiencing remarkable growth.

Musculoskeletal disorders represent a wide spectrum of health issues, and their prevalence is increasing at an alarming rate globally. As the world's population ages, the incidence of musculoskeletal disorders, particularly osteoarthritis and osteoporosis, is rising. Aging leads to a natural loss of bone density and muscle mass, making individuals more susceptible to fractures and joint degeneration. Modern lifestyles often involve extended periods of sitting, limited physical activity, and poor posture. These factors can contribute to muscle imbalances and musculoskeletal problems, including back pain and repetitive strain injuries. Obesity is a significant risk factor for musculoskeletal disorders. Excess weight places additional stress on joints, leading to conditions like osteoarthritis and lower back pain. Jobs that involve repetitive motions, heavy lifting, or prolonged periods of standing can lead to musculoskeletal injuries. Workers in industries like construction, healthcare, and manufacturing are at a higher risk. Participation in sports and physical activities carries a risk of injury, including fractures and ligament tears, which can contribute to the overall burden of musculoskeletal disorders.

Key Market Challenges

Supply Chain Constraints

One of the primary challenges facing the bone allografts market is the consistent and reliable supply of graft materials. The availability of suitable donor tissues can be affected by factors such as changes in regulations, limitations on donor pool size, and disruptions in the supply chain due to natural disasters or health crises like the COVID-19 pandemic. Ensuring a stable supply chain is essential to meet the growing demand for bone allografts.

Key Market Trends

Technological Advancements

Technological advancements have always been a catalyst for innovation and growth in various industries, and the healthcare sector is no exception. In recent years, the global bone allografts market has witnessed a remarkable surge in demand, thanks to the continuous evolution of cutting-edge technologies. Bone allografts, which involve the transplantation of bone tissue from a donor to a recipient, have become a crucial component in various orthopedic and dental procedures. Also, the partnership between two companies leads to the growth of global bone allografts market. For instance, in August 2022, Orthofix Medical Inc., a medical device company, collaborated with CGBio, a developer of synthetic bone grafts, to commercialize and advance the clinical development of Novosis recombinant human bone morphogenetic protein-2 (rhBMP-2) in the U.S. and Canadian markets.

Key Market Players

  • Zimmer Biomet inc.
  • Medtronic inc.
  • Lynch Biologics, LLC
  • Biomatlante S.A
  • Stryker Corporation
  • Royal Biologics, Inc.
  • Johnsons & Johnsons
  • Smith & Nephew plc
  • Baxter International Inc
  • Xtant Medical Hldgs.

Report Scope:

In this report, the Global Bone Allografts Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone Allografts Market, By Application:

  • Dental
  • Spine
  • Reconstruction & Traumatology
  • Others

Bone Allografts Market, By Type:

  • Cortical Bone Allografts
  • Cancellous Bone Allografts
  • Corticocancellous Bone Allografts
  • Demineralized bone Matrices

Bone Allografts Market, By End-user:

  • Hospitals & Dental Clinics
  • Orthopedic & Trauma Centers
  • Others

Bone Allografts Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bone Allografts Market.

Available Customizations:

Global Bone Allografts market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone Allografts Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Dental, Spine, Reconstruction & Traumatology, Others)
    • 5.2.2. By Type (Cortical Bone Allografts, Cancellous Bone Allografts, Corticocancellous Bone Allografts, Demineralized bone Matrices)
    • 5.2.3. By End-user (Hospitals & Dental Clinics, Orthopedic & Trauma Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (Shares of Top 5 Market Players, 2024)
  • 5.3. Market Map
    • 5.3.1. By Application
    • 5.3.2. By Type
    • 5.3.3. By End user
    • 5.3.4. By Region

6. North America Bone Allografts Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Type
    • 6.2.3. By End user
    • 6.2.4. By Country
      • 6.2.4.1. United States Bone Allografts Market Outlook
        • 6.2.4.1.1. Market Size & Forecast
        • 6.2.4.1.1.1. By Value
        • 6.2.4.1.2. Market Share & Forecast
        • 6.2.4.1.2.1. By Application
        • 6.2.4.1.2.2. By Type
        • 6.2.4.1.2.3. By End user
      • 6.2.4.2. Canada Bone Allografts Market Outlook
        • 6.2.4.2.1. Market Size & Forecast
        • 6.2.4.2.1.1. By Value
        • 6.2.4.2.2. Market Share & Forecast
        • 6.2.4.2.2.1. By Application
        • 6.2.4.2.2.2. By Type
        • 6.2.4.2.2.3. By End user
      • 6.2.4.3. Mexico Bone Allografts Market Outlook
        • 6.2.4.3.1. Market Size & Forecast
        • 6.2.4.3.1.1. By Value
        • 6.2.4.3.2. Market Share & Forecast
        • 6.2.4.3.2.1. By Application
        • 6.2.4.3.2.2. By Type
        • 6.2.4.3.2.3. By End user

7. Europe Bone Allografts Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Type
    • 7.2.3. By End user
    • 7.2.4. By Country
      • 7.2.4.1. France Bone Allografts Market Outlook
        • 7.2.4.1.1. Market Size & Forecast
        • 7.2.4.1.1.1. By Value
        • 7.2.4.1.2. Market Share & Forecast
        • 7.2.4.1.2.1. By Application
        • 7.2.4.1.2.2. By Type
        • 7.2.4.1.2.3. By End user
      • 7.2.4.2. Germany Bone Allografts Market Outlook
        • 7.2.4.2.1. Market Size & Forecast
        • 7.2.4.2.1.1. By Value
        • 7.2.4.2.2. Market Share & Forecast
        • 7.2.4.2.2.1. By Application
        • 7.2.4.2.2.2. By Type
        • 7.2.4.2.2.3. By End user
      • 7.2.4.3. United Kingdom Bone Allografts Market Outlook
        • 7.2.4.3.1. Market Size & Forecast
        • 7.2.4.3.1.1. By Value
        • 7.2.4.3.2. Market Share & Forecast
        • 7.2.4.3.2.1. By Application
        • 7.2.4.3.2.2. By Type
        • 7.2.4.3.2.3. By End user
      • 7.2.4.4. Italy Bone Allografts Market Outlook
        • 7.2.4.4.1. Market Size & Forecast
        • 7.2.4.4.1.1. By Value
        • 7.2.4.4.2. Market Share & Forecast
        • 7.2.4.4.2.1. By Application
        • 7.2.4.4.2.2. By Type
        • 7.2.4.4.2.3. By End user
      • 7.2.4.5. Spain Bone Allografts Market Outlook
        • 7.2.4.5.1. Market Size & Forecast
        • 7.2.4.5.1.1. By Value
        • 7.2.4.5.2. Market Share & Forecast
        • 7.2.4.5.2.1. By Application
        • 7.2.4.5.2.2. By Type
        • 7.2.4.5.2.3. By End user

8. Asia Pacific Bone Allografts Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Type
    • 8.2.3. By End user
    • 8.2.4. By Country
      • 8.2.4.1. China Bone Allografts Market Outlook
        • 8.2.4.1.1. Market Size & Forecast
        • 8.2.4.1.1.1. By Value
        • 8.2.4.1.2. Market Share & Forecast
        • 8.2.4.1.2.1. By Application
        • 8.2.4.1.2.2. By Type
        • 8.2.4.1.2.3. By Application
      • 8.2.4.2. India Bone Allografts Market Outlook
        • 8.2.4.2.1. Market Size & Forecast
        • 8.2.4.2.1.1. By Value
        • 8.2.4.2.2. Market Share & Forecast
        • 8.2.4.2.2.1. By Application
        • 8.2.4.2.2.2. By Type
        • 8.2.4.2.2.3. By End user
      • 8.2.4.3. South Korea Bone Allografts Market Outlook
        • 8.2.4.3.1. Market Size & Forecast
        • 8.2.4.3.1.1. By Value
        • 8.2.4.3.2. Market Share & Forecast
        • 8.2.4.3.2.1. By Application
        • 8.2.4.3.2.2. By Type
        • 8.2.4.3.2.3. By End user
      • 8.2.4.4. Japan Bone Allografts Market Outlook
        • 8.2.4.4.1. Market Size & Forecast
        • 8.2.4.4.1.1. By Value
        • 8.2.4.4.2. Market Share & Forecast
        • 8.2.4.4.2.1. By Application
        • 8.2.4.4.2.2. By Type
        • 8.2.4.4.2.3. By End user
      • 8.2.4.5. Australia Bone Allografts Market Outlook
        • 8.2.4.5.1. Market Size & Forecast
        • 8.2.4.5.1.1. By Value
        • 8.2.4.5.2. Market Share & Forecast
        • 8.2.4.5.2.1. By Application
        • 8.2.4.5.2.2. By Type
        • 8.2.4.5.2.3. By End user

9. South America Bone Allografts Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Type
    • 9.2.3. By End user
    • 9.2.4. By Country
      • 9.2.4.1. Brazil Bone Allografts Market Outlook
        • 9.2.4.1.1. Market Size & Forecast
        • 9.2.4.1.1.1. By Value
        • 9.2.4.1.2. Market Share & Forecast
        • 9.2.4.1.2.1. By Application
        • 9.2.4.1.2.2. By Type
        • 9.2.4.1.2.3. By End user
      • 9.2.4.2. Argentina Bone Allografts Market Outlook
        • 9.2.4.2.1. Market Size & Forecast
        • 9.2.4.2.1.1. By Value
        • 9.2.4.2.2. Market Share & Forecast
        • 9.2.4.2.2.1. By Application
        • 9.2.4.2.2.2. By Type
        • 9.2.4.2.2.3. By End user
      • 9.2.4.3. Colombia Bone Allografts Market Outlook
        • 9.2.4.3.1. Market Size & Forecast
        • 9.2.4.3.1.1. By Value
        • 9.2.4.3.2. Market Share & Forecast
        • 9.2.4.3.2.1. By Application
        • 9.2.4.3.2.2. By Type
        • 9.2.4.3.2.3. By End user

10. Middle East & Africa Bone Allografts Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Type
    • 10.2.3. By End user
    • 10.2.4. By Country
      • 10.2.4.1. South Africa Bone Allografts Market Outlook
        • 10.2.4.1.1. Market Size & Forecast
        • 10.2.4.1.1.1. By Value
        • 10.2.4.1.2. Market Share & Forecast
        • 10.2.4.1.2.1. By Application
        • 10.2.4.1.2.2. By Type
        • 10.2.4.1.2.3. By End user
      • 10.2.4.2. Saudi Arabia Bone Allografts Market Outlook
        • 10.2.4.2.1. Market Size & Forecast
        • 10.2.4.2.1.1. By Value
        • 10.2.4.2.2. Market Share & Forecast
        • 10.2.4.2.2.1. By Application
        • 10.2.4.2.2.2. By Type
        • 10.2.4.2.2.3. By End user
      • 10.2.4.3. UAE Bone Allografts Market Outlook
        • 10.2.4.3.1. Market Size & Forecast
        • 10.2.4.3.1.1. By Value
        • 10.2.4.3.2. Market Share & Forecast
        • 10.2.4.3.2.1. By Application
        • 10.2.4.3.2.2. By Type
        • 10.2.4.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Application Launches

13. Competitive Landscape

  • 13.1. Zimmer Biomet inc.
  • 13.2. Medtronic inc.
  • 13.3. Lynch Biologics, LLC
  • 13.4. Biomatlante S.A
  • 13.5. Stryker Corporation
  • 13.6. Royal Biologics, Inc.
  • 13.7. Johnsons & Johnsons
  • 13.8. Smith & Nephew plc
  • 13.9. Baxter International Inc
  • 13.10. Xtant Medical Hldgs.

14. Strategic Recommendations

15. About us & Disclaimer